Home Cart Sign in  
Chemical Structure| 149647-78-9 Chemical Structure| 149647-78-9

Structure of Vorinostat
CAS No.: 149647-78-9

Chemical Structure| 149647-78-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vorinostat (SAHA) is a potent, orally active pan-inhibitor of HDAC1, HDAC2, HDAC3 (Class I), HDAC6, HDAC7 (Class II), and HDAC11 (Class IV), with ID50 values of 10 nM and 20 nM for HDAC1 and HDAC3, respectively. Vorinostat induces cell apoptosis and inhibits HPV-18 DNA amplification.

Synonyms: SAHA; Suberoylanilide hydroxamic acid; MK-0683, MK 0683, MK0683, SAHA, M344, CCRIS 8456, HSDB 7930, Vorinostat, suberoylanilide hydroxamic acid, Zolinza

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Topcu, Kubra Sena Bas ; Cacan, Ercan ;

Abstract: Pancreatic cancer is one of the deadliest malignant tumours worldwide. Despite the developments in the treatments of pancreatic cancer, survival rates remain at a low level, and the mechanisms underlying the aggressive course of the cancer are not fully understood. VISTA is an immune checkpoint and has recently become a significant target in cancer treatment; however, the roles of VISTA in the development of pancreatic cancer have largely remained unknown. Histone deacetylase inhibitors (HDACi) have been reported to reverse the epithelial-mesenchymal transition (EMT) and may enhance the efficacy of anti-PD-1 therapy. The PD-L1/PD-1 immune checkpoint targeted by this therapy shares structural similarity with VISTA. Moreover, combination therapy of vorinostat and anti-PD-1 has been shown to significantly reduce tumour growth by suppressing the transcription factor c-Myc. Therefore, in this study, we aim to investigate the genes that are associated with EMT and explore the potential mechanism involving Twist1, a proto-oncogene, and VISTA in pancreatic cancer. We also sought to determine the synergistic effects of an HDACi, vorinostat, in combination with Twist1-siRNA on VISTA expression in pancreatic cancer cells’ viability and proliferation. Our results revealed that Twist1 blockade in combination with vorinostat in pancreatic cancer cells suppresses EMT-associated genes and the immune checkpoint VISTA compared to treatments administered alone. As a result, identifying the genes associated with EMT in pancreatic cancer and understanding the role of Twist1 in this process is a crucial step to contribute to the identification of new targets for pancreatic cancer treatment and the improvement of existing treatment strategies.

Keywords: EMT ; immune checkpoint ; pancreatic cancer ; Twist1 ; vorinostat

Purchased from AmBeed:

Wisam A. Dawood ; Gillian M. Fisher ; Franziska J.M. Kinnen ; Christian Anzenhofer ; Tina Skinner-Adams ; Leandro Alves Avelar , et al.

Abstract: There are more than 240 million cases of malaria and 600,000 associated deaths each year, most due to infection with Plasmodium falciparum parasites. While malaria treatment options exist, new drugs with novel modes of action are needed to address malaria parasite drug resistance. Protein lysine deacetylases (termed HDACs) are important epigenetic regulatory enzymes and prospective therapeutic targets for malaria. Here we report the antiplasmodial activity of a panel of 17 hydroxamate zinc binding group HDAC inhibitors with alkoxyamide linkers and different cap groups. The two most potent compounds (4a and 4b) were found to inhibit asexual P. falciparum growth with 50% inhibition concentrations (IC50's) of 0.07 μM and 0.09 μM, respectively, and demonstrated >200-fold more selectivity for P. falciparum parasites versus human neonatal foreskin fibroblasts (NFF). In situ hyperacetylation studies demonstrated that 4a, 4b and analogs caused P. falciparum histone H4 hyperacetylation, suggesting HDAC inhibition, with structure activity relationships providing information relevant to the design of new Plasmodium-specific aliphatic chain hydroxamate HDAC inhibitors.

Keywords: HDAC inhibitor ; Malaria ; P. falciparum ; Antiplasmodial

Purchased from AmBeed: ; ;

Haage, Verena Claudia ; Tuddenham, John F ; Bautista, Alex ; White, Charles C ; Garcia, Frankie ; Patel, Ronak , et al.

Abstract: Disease-associated microglia (DAM), initially described in mouse models of neurodegenerative diseases, have been classified into two related states; starting from a TREM2-independent DAM1 state to a TREM2 dependent state termed DAM2, with each state being characterized by the expression of specific marker genes1. Recently, single-cell (sc)RNA-Seq studies have reported the existence of DAMs in humans2-6; however, whether DAMs play beneficial or detrimental roles in the context of neurodegeneration is still under debate7,8. Here, we present a pharmacological approach to mimic human DAM in vitro by exposing different human microglia models to selected histone deacetylase (HDAC) inhibitors. We also provide an initial functional characterization of our model system, showing a specific increase of amyloid beta phagocytosis along with a reduction of MCP-1 secretion. Additionally, we report an increase in MITF expression, a transcription factor previously described to drive expression towards the DAM phenotype. We further identify CADM1, LIPA and SCIN as DAMmarker genes shared across various proposed DAM signatures and in our model systems. Overall, our strategy for targeted microglial polarization bears great potential to further explore human DAM function and biology.

Keywords: Disease-associated microglia (DAM) ; in vitro model systems ; human microglia ; functional analysis

Purchased from AmBeed: ;

Alternative Products

Product Details of Vorinostat

CAS No. :149647-78-9
Formula : C14H20N2O3
M.W : 264.32
SMILES Code : O=C(NO)CCCCCCC(NC1=CC=CC=C1)=O
Synonyms :
SAHA; Suberoylanilide hydroxamic acid; MK-0683, MK 0683, MK0683, SAHA, M344, CCRIS 8456, HSDB 7930, Vorinostat, suberoylanilide hydroxamic acid, Zolinza
MDL No. :MFCD00945317
InChI Key :WAEXFXRVDQXREF-UHFFFAOYSA-N
Pubchem ID :5311

Safety of Vorinostat

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Vorinostat

epigenetics

Isoform Comparison

Biological Activity

Target
  • HDAC

    HDAC, IC50:~10 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Breast cancer cells (MDA-MB-231) 1 µM and 3 µM 5 h daily for 4 consecutive days Vorinostat significantly decreased HDAC activity and inhibited cellular proliferation in a dose-dependent manner, with no significant effect on cell viability. PMC4884926
Prostate cancer cells (LNCaP) 1 µM and 3 µM 5 h daily for 4 consecutive days Vorinostat significantly decreased HDAC activity and inhibited cellular proliferation in a dose-dependent manner, with no significant effect on cell viability. PMC4884926
HCT-8 cells 203 nM 44 h To evaluate the inhibitory effect of Vorinostat on the growth of Cryptosporidium parvum, the results showed that Vorinostat significantly inhibited parasite growth in vitro. PMC5939870

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice IL-12 knockout mouse model Oral 7.5 mg/kg Once daily for 6 days To evaluate the inhibitory effect of Vorinostat on Cryptosporidium parvum infection in vivo, the results showed that Vorinostat significantly reduced the production of parasite oocysts. PMC5939870
Nude mice HuCC-T1 tumor model Subcutaneous injection 10 mg/kg #VALUE! Vorinostat nanofibers showed higher inhibition of tumor growth in HuCC-T1 tumor-bearing mice. PMC5655133

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00771472 Lymphoma Phase 1 Completed - -
NCT00771472 - Completed - -
NCT01064921 Stage III Squamous Cell Carcin... More >>oma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Less << Phase 1 Completed - United States, Ohio ... More >> The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00731731 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Cognitive Side Effects of Cancer Therapy Less << Phase 1 Phase 2 Active, not recruiting - -
NCT01567709 Adult B Acute Lymphoblastic Le... More >>ukemia Adult T Acute Lymphoblastic Leukemia Anaplastic Large Cell Lymphoma Angioimmunoblastic T-Cell Lymphoma Chronic Lymphocytic Leukemia Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Hepatosplenic T-Cell Lymphoma Intraocular Lymphoma Lymphomatous Involvement of Non-Cutaneous Extranodal Site Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Nodal Marginal Zone Lymphoma Primary Cutaneous B-Cell Non-Hodgkin Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-Cell Leukemia/Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Recurrent Non-Hodgkin Lymphoma Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Small Intestinal Lymphoma Splenic Marginal Zone Lymphoma T-Cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00479232 Leukemia, Myelocytic, Acute My... More >>elodysplastic Syndromes Myelodysplastic Syndromes Less << Phase 1 Completed - -
NCT00731731 - Active, not recruiting - -
NCT01267240 Paranasal Sinus Squamous Cell ... More >>Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Oral Cavity Squamous Cell Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Stage IVA Hypopharyngeal Squamous Cell Carcinoma Stage IVA Laryngeal Squamous Cell Carcinoma Stage IVA Oral Cavity Squamous Cell Carcinoma Stage IVA Oropharyngeal Squamous Cell Carcinoma Stage IVB Hypopharyngeal Squamous Cell Carcinoma Stage IVB Laryngeal Squamous Cell Carcinoma Stage IVB Oral Cavity Squamous Cell Carcinoma Stage IVB Oropharyngeal Squamous Cell Carcinoma Stage IVC Hypopharyngeal Squamous Cell Carcinoma Stage IVC Laryngeal Squamous Cell Carcinoma Stage IVC Oral Cavity Squamous Cell Carcinoma Stage IVC Oropharyngeal Squamous Cell Carcinoma Less << Phase 2 Terminated(Study treatment did... More >> not show clinical activity.) Less << - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211-1850 City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Contra Costa Regional Medical Center Martinez, California, United States, 94553-3156 Veterans Administration Hospital - Martinez Martinez, California, United States, 94553 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 Canada, Alberta Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Health Sciences Centre-Corporate London, Ontario, Canada, N6A 4L6 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Less <<
NCT02538510 Head and Neck Squamous Cell Ca... More >>rcinoma Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Recurrent Nasopharynx Carcinoma Recurrent Salivary Gland Carcinoma Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary Stage III Major Salivary Gland Carcinoma Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage III Nasopharyngeal Carcinoma Stage IV Nasopharyngeal Carcinoma Stage IVA Major Salivary Gland Carcinoma Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVB Major Salivary Gland Carcinoma Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVC Major Salivary Gland Carcinoma Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Less << Phase 1 Phase 2 Active, not recruiting June 30, 2019 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00128102 Mesothelioma ... More >>Lung Cancer Less << Phase 3 Completed - -
NCT01281176 Adult Solid Neoplasm Phase 1 Active, not recruiting - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Less <<
NCT01208454 Localized Unresectable Neurobl... More >>astoma Recurrent Neuroblastoma Regional Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma Less << Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Colorado Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta - Egleston Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01267240 - Terminated(Study treatment did... More >> not show clinical activity.) Less << - -
NCT00268385 Adult Anaplastic Astrocytoma ... More >> Adult Anaplastic Oligodendroglioma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Recurrent Adult Brain Neoplasm Less << Phase 1 Active, not recruiting - United States, Alabama ... More >> University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States, 35233 United States, California UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 UCSF Medical Center-Mount Zion San Francisco, California, United States, 94115 United States, Florida Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 National Cancer Institute Neuro-Oncology Branch Bethesda, Maryland, United States, 20892 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00729118 Multiple Myeloma ... More >> Plasma Cell Neoplasm Less << Phase 1 Active, not recruiting December 31, 2018 United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00132067 Primary Peritoneal Cavity Canc... More >>er Recurrent Ovarian Epithelial Cancer Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01492881 Multiple Myeloma Phase 2 Withdrawn(Doxil is currently u... More >>navailable) Less << January 2017 United States, North Carolina ... More >> Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT01019850 Neuroblastoma Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Salter Packer Children's Hospital Palo Alto, California, United States, 94304 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago, Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, Michigan C.S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 United States, Texas Cook Children's Medical Center - Fort Worth Fort Worth, Texas, United States, 76104 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00731952 Non Small Cell Lung Cancer Phase 1 Completed - United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT00798720 Carcinoma, Non Small Cell Lung Phase 2 Completed - -
NCT00857324 Multiple Myeloma PHASE1|PHASE2 TERMINATED 2025-05-17 Dipartimento Medicina Clinica ... More >>e Sperimentale, Padova, 35128, Italy|A.O.U. S. Giovanni Battista, Torino, 10126, Italy|Policlinico Universitario di Udine, Udine, 33100, Italy|Azienda Ospedaliera di Verona - Policlinico G.B. Rossi, Verona, 37134, Italy Less <<
NCT00798720 - Completed - -
NCT00907738 Advanced Cancer Phase 2 Completed - -
NCT00907738 - Completed - -
NCT00818649 - Terminated(Met protocol stop r... More >>ule [i.e., extreme toxicity]) Less << - -
NCT00818649 Leukemia Myel... More >>odysplastic Syndrome Less << Phase 2 Terminated(Met protocol stop r... More >>ule [i.e., extreme toxicity]) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00662311 - Terminated - -
NCT00662311 Stage IIIA Non-small Cell Lung... More >> Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 1 Phase 2 Terminated - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00810576 - Terminated(Terminated due to s... More >>low accrual.) Less << - -
NCT03150329 Grade 3a Follicular Lymphoma ... More >> Grade 3b Follicular Lymphoma Recurrent Classical Hodgkin Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Classical Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma Less << Phase 1 Recruiting July 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Alex F. Herrera, MD    626-256-4673 ext 62405    aherrera@coh.org    Principal Investigator: Alex F. Herrera, MD          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Tatyana Feldman, MD    551-996-4469    Tatyana.Feldman@hackensackmeridian.org    Principal Investigator: Tatyana Feldman, MD Less <<
NCT00479232 - Completed - -
NCT00810576 Lymphoma Phase 2 Terminated(Terminated due to s... More >>low accrual.) Less << - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01600742 Brain Metastasis Phase 2 Terminated(Sponsor stops to pr... More >>ovide the study drug.) Less << - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00918723 Chronic Lymphocytic Leukemia ... More >> Stage I Chronic Lymphocytic Leukemia Stage I Small Lymphocytic Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Small Lymphocytic Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma Less << Phase 1 Phase 2 Active, not recruiting October 2019 United States, Washington ... More >> Swedish Cancer Institute-Breast Center at First Hill Campus Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00918723 - Active, not recruiting - -
NCT01039363 Acute Myeloid Leukemia Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 135-710 Principal Investigator: Dong Hwan Won, M.D.,Ph.D. Less <<
NCT01118975 Breast Cancer ... More >> Neoplasm Metastasis Less << Phase 1 Phase 2 Terminated(Lost sponsorship fo... More >>r study drug) Less << - United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Less <<
NCT01118975 - Terminated(Lost sponsorship fo... More >>r study drug) Less << - -
NCT00565227 Non-Small-Cell Lung Carcinoma ... More >> Prostate Cancer Bladder Cancer Urothelial Carcinoma Less << Phase 1 Terminated(closed due to toxic... More >>ity) Less << - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00324740 - Terminated - -
NCT01608139 Advanced Cancers Phase 1 Withdrawn - -
NCT01421173 Lymphoma Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00111813 Multiple Myeloma Phase 1 Completed - -
NCT00785798 Relapsed Lymphomas ... More >> Refractory Lymphomas Less << Phase 1 Phase 2 Terminated(sponsor requested) - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00111813 - Completed - -
NCT01550224 - Completed - -
NCT01550224 Acute Myeloid Leukemia With 11... More >>q23-abnormality in Relapse Less << Phase 2 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 Less <<
NCT01297764 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting August 2019 United States, New Jersey ... More >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00324740 Recurrent Renal Cell Cancer ... More >> Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Terminated - United States, New York ... More >> Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467-2490 Weill Medical College of Cornell University New York, New York, United States, 10065 Less <<
NCT00635791 Malignant Solid Tumour ... More >> Renal Cell Carcinoma Non Small Cell Lung Carcinoma Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less <<
NCT01728805 Cutaneous T-Cell Lymphoma Phase 3 Active, not recruiting December 2018 -
NCT00121225 Ciliary Body and Choroid Melan... More >>oma, Medium/Large Size Extraocular Extension Melanoma Iris Melanoma Uveal Melanoma Recurrent Intraocular Melanoma Recurrent Melanoma Stage IV Melanoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Fox Chase Cancer Center Rockledge, Pennsylvania, United States, 19046 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada, M5G 2M9 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00785798 - Terminated(sponsor requested) - -
NCT00486720 Myelodysplastic Syndromes ... More >> Blood Disease Bone Marrow Disease Less << Phase 2 Terminated - -
NCT00910000 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Cancer Less << Phase 1 Phase 2 Terminated(Terminated due to u... More >>nacceptable toxicity) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00486720 - Terminated - -
NCT00121225 - Completed - -
NCT00910000 - Terminated(Terminated due to u... More >>nacceptable toxicity) Less << - -
NCT01000155 Sickle Cell Disease ... More >> Sickle Cell Anemia Less << Phase 2 Terminated(The study terminate... More >>d early due to slow accrual.) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01000155 - Terminated(The study terminate... More >>d early due to slow accrual.) Less << - -
NCT01587352 Ocular Melanoma With Extraocul... More >>ar Extension Recurrent Uveal Melanoma Stage IV Uveal Melanoma AJCC v7 Less << Phase 2 Terminated - United States, New York ... More >> Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00503971 Non-small Cell Lung Cancer Phase 1 Phase 2 Terminated - Spain ... More >> Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Instituto Universitario Dexeus Barcelona, Spain, 08028 Hospital Clinic Barcelona, Spain, 08036 Institut Catalá d'Oncologia, Centre Sanitari i Universitari de Bellvitge (CSUB) Barcelona, Spain, 08907 Institut Catalá d'Oncología, Hospital Germans Trias i Pujol Barcelona, Spain, 08916 Hospital La Paz Madrid, Spain, 28046 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Hospital Clínico Lozano Blesa Zaragoza, Spain, 50009 Less <<
NCT00773838 Relapsed or Refractory Multipl... More >>e Myeloma Less << Phase 2 Completed - -
NCT00776503 Myelodysplastic Syndromes Phase 1 Phase 2 Completed - France ... More >> Hôpital de la Durance Avignon, France, 84902 Hopital Avicenne Bobigny, France, 93009 CH René Dubos Cergy-pontoise, France, 95303 Hematology Dpt, Hôpital Sud Francilien Corbeil-essonnes, France, 91100 CHU Grenoble Grenoble, France, 38043 Hôpital Edouard Heriot, dpt Hématologie Clinique Lyon, France, 69437 Hematology Dpt, Institut Paoli Calmettes Marseille, France, 13009 Hematology Dpt, Hopital de l'Hotel Dieu Nantes, France, 44093 Hematology Dpt, Hopital Saint Louis Paris, France, 75475 Hematology Dpt, Hopital Cochin Paris, France, 75679 Centre Henri Bequerel Rouen, France, 76038 Centre René Huguenin Saint Cloud, France, 92210 Hematology Dpt, Hopital Haute Pierre Strasbourg, France, 67098 Hematology Dpt, Hopital Purpan Toulouse, France, 40031 Less <<
NCT00773747 Multiple Myeloma Phase 3 Completed - -
NCT00810602 - Completed - -
NCT01110876 Brain Cancer ... More >>Glioblastoma Multiforme Less << Phase 1 Phase 2 Terminated(Unanticipated Toxic... More >>ities) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01790568 - Completed - -
NCT00561418 Lymphoma Smal... More >>l Intestine Cancer Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00810602 Hematologic Malignancies ... More >> Graft vs Host Disease Less << Phase 1 Phase 2 Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00561418 - Completed - -
NCT01319383 HIV-1 Infection PHASE1|PHASE2 COMPLETED 2016-03-31 The University of North Caroli... More >>na at Chapel Hill, Chapel Hill, North Carolina, 27514, United States Less <<
NCT01790568 Graft vs Host Disease ... More >> Hematologic Neoplasms Non-Neoplastic Hematologic and Lymphocytic Disorder Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00667082 Non-Small Cell Lung Cancer ... More >> Pancreatic Cancer Melanoma Lymphoma Multiple Myeloma Less << Phase 1 Completed - Australia, South Australia ... More >> Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 The Queen Elizabeth Hospital Woodville South, South Australia, Australia, 5011 Australia, Western Australia Sir Charles Gairdner Hospital and University of Western Australia Nedlands, Western Australia, Australia, 6009 Less <<
NCT01534260 - Completed - -
NCT01266057 Advanced Cancers Phase 1 Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01187446 - Terminated(Business decision b... More >>y funding source) Less << - -
NCT01187446 Cutaneous Lymphoma ... More >> Cutaneous T-cell Lymphoma Less << Phase 1 Phase 2 Terminated(Business decision b... More >>y funding source) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 United States, Connecticut Yale University School of Medicine New Haven, Connecticut, United States, 06520 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01422499 Children With Relapsed Solid T... More >>umor, Lymphoma or Leukemia Less << Phase 1 Phase 2 Completed - Germany ... More >> Clinic for Pediatric Oncology, Hematology, Immunology and Clinical Cooperation Unit Pediatric Oncology Heidelberg, BW, Germany, 69198 Childrens's Hospital, Pediatric Oncology and Hematology Augsburg, Germany, 86156 Prof. Hess Childrens's Hospital, Pediatric Oncology and Hematology Bremen, Germany, 28205 University Childrens's Hospital, Pediatric Oncology and Hematology Essen, Germany, 45122 University Children's Hospital, Clinic IV Freiburg, Germany, 79106 Department of Pediatric Oncology and Hematology University Hospital Eppendorf (UKE) Hamburg, Germany, 20246 University Children's Hospital, Pediatric Oncology and Hematology, MHH Hannover, Germany, 30625 University Childrens's Hospital, Pediatric Oncology and Hematology Jena, Germany, 07743 University Children's Hospital, Pediatric Oncology and Hematology Köln, Germany, 50937 Department of Pediatric Oncology and Hematology University Children's Hospital Münster, Germany, 48149 Less <<
NCT01319383 HIV-1 Infection PHASE1|PHASE2 COMPLETED 2016-03-31 The University of North Caroli... More >>na at Chapel Hill, Chapel Hill, North Carolina, 27514, United States Less <<
NCT01534260 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00499811 Adult Grade III Lymphomatoid G... More >>ranulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Primary Central Nervous System Hodgkin Lymphoma Primary Central Nervous System Non-Hodgkin Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 University of Southern California Los Angeles, California, United States, 90033 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Maryland National Institutes of Health Bethesda, Maryland, United States, 20892 United States, Michigan Wayne State University-Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 United States, West Virginia West Virginia University Healthcare Morgantown, West Virginia, United States, 26506 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00772798 Ovarian Cancer Phase 2 Unknown June 2009 Denmark ... More >> Department of Oncology R Recruiting Odense, Denmark, DK-5000 C Less <<
NCT01059552 Locally Advanced Non-small Cel... More >>l Lung Cancer Less << Phase 1 Active, not recruiting December 1, 2018 United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT00667615 - Completed - -
NCT01502085 Multiple Myeloma Phase 1 Phase 2 Unknown May 2016 United States, New Jersey ... More >> John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00667615 Hodgkin's Disease ... More >> Lymphoma Less << Phase 1 Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center @ BaskingRidge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Cornell Medical Center New York, New York, United States Memorial Sloan Kettering Cancer Center @ Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT02638090 Lung Cancer N... More >>on-small Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting November 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Germaine Gonzalez-Vazquez    813-745-6636    germaine.gonzalezvazquez@moffitt.org    Contact: Jhanelle Gray, M.D.    813-745-7282    jhanelle.gray@moffitt.org    Principal Investigator: Jhanelle Gray, M.D.          Sub-Investigator: Scott Antonia, M.D., Ph.D.          Sub-Investigator: Ben Creelan, M.D.          Sub-Investigator: Eric Haura, M.D.          Sub-Investigator: Tawee Tanvetyanon, M.D.          Sub-Investigator: Charles Williams, Jr., M.D. Less <<
NCT00697476 Small Cell Lung Cancer Phase 1 Phase 2 Terminated(insufficient enroll... More >>ment) Less << - Italy ... More >> Istituto Clinico Humanitas Rozzano, Milan, Italy, 20089 Less <<
NCT00831493 - Terminated(Slow Accrual.) - -
NCT00972842 Peripheral T-Cell Non-Hodgkin'... More >>s Lymphoma Less << Phase 1 Phase 2 Terminated(slow recruitment) - Austria ... More >> Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tirol, Austria, A-6020 Krankenhaus der Elisabethinen Linz Linz, Austria, A-4010 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 Hanusch Krankenhaus Vienna, Austria, A-1140 Less <<
NCT02420613 Diffuse Intrinsic Pontine Glio... More >>ma Less << Phase 1 Recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00831493 Pancreatic Cancer Phase 1 Phase 2 Terminated(Slow Accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00948688 - Terminated(Funding was withdra... More >>wn after only 10 participants were enrolled) Less << - -
NCT01075113 Liver Cancer Phase 1 Active, not recruiting January 31, 2023 United States, Virginia ... More >> Hunter Holmes McGuire VA Medical Center Richmond, Virginia, United States, 23249 Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT01276717 Lymphoma Phase 1 Completed - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 United States, Virginia Virginia Commonwealth University Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00948688 Pancreatic Cancer ... More >> Adenocarcinoma of the Pancreas Less << Phase 1 Phase 2 Terminated(Funding was withdra... More >>wn after only 10 participants were enrolled) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00976183 - Terminated(toxicities) - -
NCT00821951 - Completed - -
NCT01266031 - Completed - -
NCT01266031 Malignant Glioma ... More >> Recurrent Glioblastoma Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> Baylor University Medical Center Dallas, Texas, United States, 75246 Less <<
NCT01748240 Myelodysplastic Syndrome Phase 2 Terminated(inefficiency) - France ... More >> CHU d'Angers Angers, France, 49033 CH Annecy Annecy, France, 74374 Hôpital Avignon Avignon, France, 84000 Centre hospitalier de la côte Basque Bayonne, France, 64100 Hôpital Avicenne Bobigny, France, 93009 CHU de Haut-Lévèque Bordeaux Pessac, France, 33604 CHU de Grenoble Grenoble, France, 38043 CH Le mans Le mans, France, 72037 CH Lyon Sud Lyon, France, 69495 IPC-Unité d'Hématologie 3 Marseille, France, 13273 CHU Nantes Nantes, France, 44093 Hôpital Archet1 Nice, France, 06202 GHU Caremeau Nimes, France, 30029 Hôpital Saint Louis Paris, France, 75010 Hopital Saint Louis - AP-HP, Hematology Dpt Paris, France, 75475 Hôpital Saint-Louis Paris, France, 75475 Hopital Cochin-Hematology Paris, France, 75679 Centre Hospitalier Joffre Perpignan, France, 66046 Centre Henri Becquerel Rouen, France, 76038 Hopital Purpan-Medecine interne Toulouse, France, 31059 Hôpital PURPAN, Service d'Hématologie Clinique Toulouse, France, 31059 CHU Bretonneau Tours, France, 37044 CH de Valence Valence, France, 26953 CHU Brabois Vandoeuvre, France, 54511 Less <<
NCT00976183 Ovarian Neoplasms Phase 1 Phase 2 Terminated(toxicities) - United States, California ... More >> Gynecologic Oncology Associates Newport Beach, California, United States, 92663 Less <<
NCT01748240 - Terminated(inefficiency) - -
NCT01339871 Advanced Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02589145 Lymphoma Phase 1 Phase 2 Active, not recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00821951 Non-Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 1 Completed - United States, Connecticut ... More >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT03198559 HIV Infections Phase 1 Phase 2 Suspended(Review of current ad... More >>verse events reported by study participants) Less << July 2027 Australia, Victoria ... More >> Department of Infectious Diseases, Alfred Hospital Melbourne, Victoria, Australia, 3004 Less <<
NCT00838929 Brain Metastases Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, Texas The University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00875745 Leukemia, Myeloid, Acute ... More >> Leukemia, Promyelocytic, Acute Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00801151 Malignant Solid Tumour Phase 1 Terminated - France ... More >> Centre René GAUDUCHEAU Nantes Saint Herblain, France, 44805 Institut Curie Paris, France, 75005 Institut Claudius REGAUD Toulouse, France, 31052 Less <<
NCT00838929 - Completed - -
NCT01194427 Stage I Breast Cancer ... More >> Stage II Breast Cancer Stage III Breast Cancer Invasive Breast Cancer Less << Phase 2 Terminated(Difficulty meeting ... More >>patient accrual goals) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 Less <<
NCT01194427 - Terminated(Difficulty meeting ... More >>patient accrual goals) Less << - -
NCT01720875 Multiple Myeloma Phase 2 Unknown August 2017 United Kingdom ... More >> Nottingham University Hospital Nottingham, Nottinghamshire, United Kingdom, NG5 1PB University Hospital Southampton Southampton, United Kingdom, SO16 6YD Less <<
NCT00735826 Aerodigestive Tract Cancer|Lun... More >>g Cancer|Esophageal Cancer|Head and Neck Cancer Less << COMPLETED 2025-07-12 Dartmouth-Hitchcock Medical Ce... More >>nter, Lebanon, New Hampshire, 03756, United States Less <<
NCT00735826 Aerodigestive Tract Cancer|Lun... More >>g Cancer|Esophageal Cancer|Head and Neck Cancer Less << COMPLETED 2025-07-12 Dartmouth-Hitchcock Medical Ce... More >>nter, Lebanon, New Hampshire, 03756, United States Less <<
NCT01023737 Malignant Solid Tumour Phase 1 Active, not recruiting September 2020 United States, Texas ... More >> Cancer Therapy & Research Center University of Texas Health Science Center San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00918489 Soft Tissue Sarcoma PHASE2 COMPLETED 2025-09-13 Department of Hematology, Onco... More >>logy, Rheumatology and Immunology, University Hospital Tübingen, Tübingen, Baden-Württemberg, D-72076, Germany|Department of Hematology, Hemostaseology, Oncology and Stemm Cell Transplantation, Medical School Hannover, Hannover, Niedersachen, D-30625, Germany|Department of Oncology, Hematology and Palliative Medicine, Marien Hospital Düsseldorf, Düsseldorf, Nordrhein-Westfalen, D-40479, Germany|Comprehensive Cancer Center North, University Hospital Kiel, Kiel, 24105, Germany|Sarcoma Center Mannheim, University Hospital Mannheim, Mannheim, 68167, Germany|Center for Soft Tissue Sarcoma, University Hospital Tübingen, Tübingen, 72074, Germany|Comprehensive Cancer Center Ulm (CCCU), Ulm, 89081, Germany Less <<
NCT00702962 - Terminated(Poor accrual) - -
NCT02042989 Advanced Cancers Phase 1 Active, not recruiting June 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02124083 Neimann-Pick Disease PHASE1|PHASE2 COMPLETED 2016-12-13 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT00702962 Small Cell Lung Cancer Phase 1 Phase 2 Terminated(Poor accrual) - United States, Pennsylvania ... More >> Penn State College of Medicine, Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT02151721 Non-Small-Cell Lung Carcinoma Phase 1 Active, not recruiting February 20, 2018 Japan ... More >> Nagoya University Graduate School of Medicine Nagoya, Aichi, Japan, 466-8560 Institute of Biomedical Research and Innovation Hospital Kobe, Hyogo-ken, Japan, 650-0047 Kanazawa University Hospital Kanazawa, Ishikawa, Japan, 920-0934 Tohoku University Hospital Sendai, Miyagi, Japan, 980-8574 Shizuoka Cancer Center Sunto-gun, Shizuoka, Japan, 411-8777 Less <<
NCT02619253 Renal Cell Carcinoma ... More >> Urinary Bladder Neoplasms Less << Phase 1 Recruiting May 31, 2020 United States, California ... More >> USC/Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Charis Barg, RN    323-865-0845    charis.barg@med.usc.edu    Principal Investigator: David Quinn, MD          United States, Indiana Indiana University Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Marietta Moore, RN    317-274-7477    marlmoor@iu.edu    Principal Investigator: Roberto Pili, MD          Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Marietta Moore, RN    317-274-7477    marlmoor@iu.edu    Principal Investigator: Roberto Pili, MD          IU Health Central Indiana Cancer Centers (CICC) Recruiting Indianapolis, Indiana, United States, 46219 Contact: Deb Racster, RN    317-727-6549    dracster@iuhealth.org    Principal Investigator: Andrew Greenspan, MD          United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21205 Contact: Connie Collins    410-955-1017    ccolli23@jhmi.edu    Principal Investigator: Noah Hahn, MD Less <<
NCT02124083 Neimann-Pick Disease PHASE1|PHASE2 COMPLETED 2016-12-13 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT01365065 HIV Positive PHASE2 UNKNOWN 2025-01-18 The Alfred Hospital - Infectio... More >>us Diseases Unit, Melbourne, Victoria, 3004, Australia Less <<
NCT02836548 Melanoma|Skin Neoplasms PHASE1|PHASE2 UNKNOWN 2025-10-19 Netherlands Cancer Institute -... More >> Antoni van Leeuwenhoek Hospital, Amsterdam, 1066 CX, Netherlands Less <<
NCT01294670 Solid Tumors ... More >>Relapsed/Refractory Sarcomas Less << Phase 1 Phase 2 Active, not recruiting February 2019 United States, Arizona ... More >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, Colorado Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Florida Arnold Palmer Hospital for Children/MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 All Children's Hospital Saint Petersburg, Florida, United States, 33701 United States, Maryland John Hopkins Medical Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Children's Mercy Hospital & Clinics Kansas City, Missouri, United States, 64108 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania Pennsylvania State University College of Medicine Hershey, Pennsylvania, United States, 17110 United States, Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Alberta Alberta Children'S Hospital Calgary, Alberta, Canada, T2N 1N4 Less <<
NCT02707900 HIV-1 Infection Phase 1 Terminated(Manufacturing of th... More >>e AGS-004 HIV vaccine by Argos could no longer be provided.) Less << - United States, North Carolina ... More >> University of North Carolina Hospitals Chapel Hill, North Carolina, United States, 27599-7030 Less <<
NCT03742245 Breast Cancer Metastatic ... More >> Breast Cancer Less << Phase 1 Not yet recruiting September 1, 2022 United States, Texas ... More >> Houston Methodist Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01500538 Follicular Lymphoma ... More >> Marginal Zone Lymphoma Mantle Cell Lymphoma Less << Phase 2 Terminated(Poor recruitment ra... More >>te) Less << - Australia, Victoria ... More >> Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 3002 Less <<
NCT03056495 Alzheimer Disease Phase 1 Recruiting October 2019 Germany ... More >> German Center for Neurodegenerative Diseases Recruiting Bonn, Germany, 53127 Contact: Anja Schneider, Prof. Dr. med.    0049-228-287-1137    anja.schneider@dzne.de    University Medical Center Göttingen, Department of Psychiatry and Psychotherapy Recruiting Göttingen, Germany, 37075 Contact: Jens Wiltfang, Prof. Dr. med.    0049-551-3966601    jens.wiltfang@med.uni-goettingen.de Less <<
NCT03509207 Leiomyosarcoma ... More >> Endometrial Stromal Tumors Carcinosarcomas Uterine Less << Phase 2 Recruiting December 31, 2019 Austria ... More >> Medical University of Graz, Clinic of Obstetrics and Gynecology Recruiting Graz, Austria, 8036 Contact: Edgar Petru, Prof. MD    +43 316 385 ext 13810    edgar.petru@medunigraz.at    Principal Investigator: Edgar Petru, MD Less <<
NCT03022565 Uveal Melanoma EARLY_PHASE1 WITHDRAWN 2020-01-29 -
NCT01578343 Mantle Cell Lymphoma Phase 2 Terminated(we collected data o... More >>f a total of 19 patients for an interim analysis. but there are less than 7 responses out of the initial 19 patients.) Less << - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01045538 Gastric Cancer ... More >> Histone Deacetylase Inhibitor Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02645149 Melanoma Phase 4 Not yet recruiting August 2021 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez    612 9911 7200    maria.gonzalez@melanoma.org.au    Principal Investigator: John Thompson          Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez    +612 9911 7200    maria.gonzalez@melanoma.org.au    Contact: Alex Menzies    +612 9911 7200    info@melanoma.org.au    Sub-Investigator: Georgina Long          Principal Investigator: Alex Menzies Less <<
NCT01142375 - Unknown - -
NCT00007345 Cutaneous T Cell Lymphoma ... More >> Peripheral T Cell Lymphoma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259 United States, Arkansas University of Arkansas Little Rock, Arkansas, United States, 72205 United States, California City of Hope National Cancer Center Duarte, California, United States, 91010 Mercy General Hospital Sacramento, California, United States, 95819 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007-2197 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New York North Shore University Hospital Manhasset, New York, United States, 11030 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15261 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 Australia Royal Adelaide Hospital Adelaide, Australia Peter MacCallum Cancer Centre Melbourne, Australia Sir Charles Gairdner Hospital Perth, Australia Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00007345 - Completed - -
NCT01655004 Breast Carcinoma Not Applicable Unknown August 2018 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Andrea LA Wong, MBBS    (65) 6772 5934    andrea_la_wong@nuhs.edu.sg    Sub-Investigator: Soo Chin Lee, MBBS          Sub-Investigator: Siew Eng Lim, MBBS          Sub-Investigator: Sing Huang Tan, MBBS Less <<
NCT03117751 Acute Lymphoblastic Leukemia ... More >> Acute Lymphoblastic Lymphoma Less << Phase 2 Phase 3 Recruiting March 31, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Hiroto Inaba, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Hiroto Inaba, MD, PhD Less <<
NCT01663571 - Terminated(Study is permanentl... More >>y closed to enrollment .Collection of private identifiable information is complete Analysis of private identifiable information is complete) Less << - United States, New York ... More >> NYU Langone Medical Center New York, New York, United States, 10016 Less <<
NCT02559778 Neuroblastoma Phase 2 Recruiting September 2026 -
NCT00858234 Multiple Myeloma Phase 1 Completed - -
NCT02553460 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting October 2031 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Paul Gaynon, MD    323-361-4110    pgaynon@chla.usc.edu    Principal Investigator: Paul Gaynon, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 Contact: Ivan Kirov, MD    714-997-3000    ikirov@choc.org    Principal Investigator: Ivan Kirov, MD          Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5983    dschiff@chsd.org    Principal Investigator: Deborah Schiff, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Michael Richards, MD    612-813-5193    Michael.richards@childrensmn.org    Principal Investigator: Michael Richards, MD          United States, North Carolina St. Jude Affiliate-Charlotte Recruiting Charlotte, North Carolina, United States, 28204 Contact: Christine Bolen, MD    704-384-1900    cybolen@novanthealth.org    Principal Investigator: Christine Bolen, MD          United States, Ohio Cincinnati Children's Hospital Recruiting Cincinnati, Ohio, United States, 45229 Contact: Erin Breese, MD, PhD    513-636-2799    erin.breese@cchmc.org    Principal Investigator: Erin Breese, MD, PhD          Rainbow Babies & Children's Hospital Recruiting Cleveland, Ohio, United States, 44106 Contact: Yousif Matloub, MD    216-844-5437    yousif.matloub@uhhospitals.org    Principal Investigator: Yousif Matloub, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Bill Chang, MD    503-494-1080    changb@ohsu.edu    Principal Investigator: Bill Chang, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    tanja.gruber@stjude.org    Contact: Referral Office    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD          United States, Virginia Children's Hospital of the King's Daughters (CHKD) Recruiting Norfolk, Virginia, United States, 23507 Contact: Eric Lowe, MD    757-668-7243    eric.lowe@chkd.org    Principal Investigator: Eric Lowe, MD          Canada, Alberta Alberta Children's Hospital Recruiting Calgary, Alberta, Canada, T3A 6A8 Contact: Victor A. Lewis, MD    403-220-6898    victor.lewis@ahs.ca    Principal Investigator: Victor A. Lewis, MD          Stollery Children's Hospital Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Sunil Desai, M.B.Ch.B., FRCP(c)    780-248-5415    sunil.desai@ahs.ca    Principal Investigator: Sunil Desai, M.B.Ch.B., FRCP(c)          Canada, British Columbia Children's & Women's Health Centre of British Columbia Recruiting Vancouver, British Columbia, Canada, V6H 3V4 Contact: Kirk R. Schultz, MD    604-875-2345 ext 6477    kschultz@mail.ubc.ca    Principal Investigator: Kirk R. Schultz, MD          Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L85 4J9 Contact: Uma Athale, MD    905-521-2100 ext 73376    athaleu@mcmaster.ca    Principal Investigator: Uma Athale, MD          Canada, Quebec The Montreal Children's Hospital (MUHC-McGill) Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Catherine Vezina, MD    514-412-4445    catherine.vezina@muhc.mcgill.ca    Principal Investigator: Catherine Vezina, MD          Centre Hospitalier Universitaire Sainte-Justine Recruiting Montreal, Quebec, Canada, HcT 1C5 Contact: Henrique Bittencourt, MD    514-345-4931    henrique.bittencourt.hsj@ssss.gouv.qc.ca    Contact: Yvan Samson       yvan.samson@umontreal.ca    Principal Investigator: Henrique Bittencourt, MD          Centre Hospitalier Universitaire de Quebec Recruiting Québec, Quebec, Canada, G1V 4G2 Contact: Bruno Michon, MD    418-525-4444    bruno.michon@mail.chuq.qc.ca    Principal Investigator: Bruno Michon, MD Less <<
NCT03259503 Malignant Neoplasms Stated as ... More >>Primary Lymphoid Haematopoietic Lymphoma Less << Phase 1 Phase 2 Not yet recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       ynieto@mdanderson.org Less <<
NCT01249443 HIV Infection ... More >> Recurrent Anal Cancer Recurrent Breast Cancer Recurrent Esophageal Cancer Recurrent Gastric Cancer Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Non-small Cell Lung Cancer Recurrent Ovarian Epithelial Cancer Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Anal Cancer Stage IV Breast Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer Stage IV Non-small Cell Lung Cancer Stage IV Ovarian Epithelial Cancer Stage IV Salivary Gland Cancer Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IV Verrucous Carcinoma of the Larynx Stage IV Verrucous Carcinoma of the Oral Cavity Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated(Inadequate accrual ... More >>rate) Less << - United States, California ... More >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States, 90035 United States, District of Columbia Lombardi Comprehensive Cancer Center at Georgetown University Washington, District of Columbia, United States, 20057 United States, Florida University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States, 33136 United States, Illinois John H. Stroger Jr. Hospital of Cook County Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Medical Center Boston, Massachusetts, United States, 02118 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467-2490 United States, Pennsylvania Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Washington Benaroya Research Institute at Virginia Mason Seattle, Washington, United States, 98101-2795 Less <<
NCT02114502 Myeloma Phase 2 Withdrawn - -
NCT00424775 - Terminated - -
NCT02336074 HIV Phase 2 Active, not recruiting November 2022 United Kingdom ... More >> Brighton and Sussex University Hospitals NHS Trust Brighton, United Kingdom Central and North West London NHS Foundation Trust London, United Kingdom Chelsea and Westminster NHS Foundation Trust London, United Kingdom Guy's and St Thomas' NHS Foundation Trust London, United Kingdom Imperial College Healthcare NHS Trust London, United Kingdom Royal Free Hospital NHS Foundation Trust London, United Kingdom Less <<
NCT03382834 HIV Infections Early Phase 1 Active, not recruiting June 30, 2023 United States, Alabama ... More >> Alabama CRS Birmingham, Alabama, United States, 35294 United States, California UCLA CARE Center CRS Los Angeles, California, United States, 90035 Ucsf Hiv/Aids Crs San Francisco, California, United States, 94110 Harbor-UCLA CRS Torrance, California, United States, 90502 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80045 United States, District of Columbia Whitman-Walker Health CRS Washington, District of Columbia, United States, 20005 United States, Georgia The Ponce de Leon Center CRS Atlanta, Georgia, United States, 30308-2012 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Massachusetts Massachusetts General Hospital CRS (MGH CRS) Boston, Massachusetts, United States, 02114 United States, New Jersey New Jersey Medical School Clinical Research Center CRS Newark, New Jersey, United States, 07103 United States, North Carolina Chapel Hill CRS Chapel Hill, North Carolina, United States, 27599 Greensboro CRS Greensboro, North Carolina, United States, 27401 United States, Ohio Cincinnati Clinical Research Site Cincinnati, Ohio, United States, 45219 United States, Pennsylvania Penn Therapeutics, CRS Philadelphia, Pennsylvania, United States, 19104 Puerto Rico Puerto Rico AIDS Clinical Trials Unit CRS San Juan, Puerto Rico, 00935 Less <<
NCT02412475 Leukemia, Acute Myeloid Phase 1 Active, not recruiting February 2019 United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00424775 Neoplasms Phase 1 Terminated - -
NCT00750178 Cancer, Advanced Phase 1 Completed - -
NCT00097929 B-cell Lymphoma Phase 2 Completed - -
NCT00126451 Breast Cancer ... More >> Colorectal Cancer Non-small-cell Lung Carcinoma Less << Phase 2 Terminated - -
NCT00091559 Cutaneous T-cell Lymphoma ... More >> Sezary Syndrome Mycosis Fungoides Less << Phase 2 Completed - -
NCT02475915 Acute HIV Infection Phase 1 Phase 2 Completed - Thailand ... More >> SEARCH, the Thai Red Cross AIDS Research Centre Bangkok, Thailand, 10330 Less <<
NCT03713320 Cutaneous T-Cell Lymphoma/Myco... More >>sis Fungoides Less << Phase 2 Recruiting September 2021 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Rosemarie Abary    626-218-8087    rabary@coh.org    Principal Investigator: Christiane Querfeld, MD          Chao Family Comprehensive Cancer Center at University of California, Irvine Recruiting Orange, California, United States, 92868 Contact: Blake Johnson    714-456-3476    Blakej@uci.edu    Principal Investigator: Lauren Pinter-Brown, MD          United States, Connecticut Smilow Cancer Hospital at Yale-New Haven Not yet recruiting New Haven, Connecticut, United States, 06510 Principal Investigator: Francine Foss, MD          United States, Florida Moffitt Cancer Center Not yet recruiting Tampa, Florida, United States, 33612 Principal Investigator: Lubomir Sokol, MD, PhD          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63108 Contact: Mary Tabacchi, CCRC    314-362-8171    mtabacch@wustl.edu    Principal Investigator: Amy Musiek, MD          United States, New York Rochester Skin Lymphoma Medical Group Not yet recruiting Fairport, New York, United States, 14450 Principal Investigator: Brian Poligone, MD, PhD          United States, Ohio The Ohio State University Comprehensive Cancer Center Not yet recruiting Columbus, Ohio, United States, 43210 Principal Investigator: Basem William, MD          Canada, Alberta Cross Cancer Institute Not yet recruiting Edmonton, Alberta, Canada, T6G 1Z2 Principal Investigator: Minakshi Taparia, MD          Canada, Ontario Princess Margaret Cancer Centre Not yet recruiting Toronto, Ontario, Canada, M5G 2C1 Principal Investigator: Vishal Kukreti, MD          Canada, Quebec Jewish General Hospital Not yet recruiting Montréal, Quebec, Canada, H3T 1E2 Principal Investigator: Kevin Pehr, MD Less <<
NCT00127101 Lymphoma Phase 1 Terminated(The study was stopp... More >>ed due to low enrollment.) Less << - -
NCT00127101 - Terminated(The study was stopp... More >>ed due to low enrollment.) Less << - -
NCT02395627 Breast Neoplasms Phase 2 Recruiting August 1, 2019 United States, California ... More >> University of California, San Francisco Medical Center Recruiting San Francisco, California, United States, 94115 Contact: Amy DeLuca    877-827-3222    cancertrials@ucsf.edu    Principal Investigator: Pamela Munster, MD Less <<
NCT00217412 Childhood Acute Promyelocytic ... More >>Leukemia (M3) Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Juvenile Myelomonocytic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Medulloblastoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Neuroblastoma Recurrent/Refractory Childhood Hodgkin Lymphoma Relapsing Chronic Myelogenous Leukemia Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Pennsylvania ... More >> Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00816283 Leukemia Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 City of Hope Medical Group Pasadena, California, United States, 91105 Less <<
NCT02409134 - Completed - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT00875056 Lymphoma PHASE2 COMPLETED 2019-02-08 -
NCT00005634 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Prostate Cancer Small Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00310024 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Completed - United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 Less <<
NCT01983969 Advanced Cancers ... More >> Lymphoma Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02035137 Neuroblastoma Phase 2 Recruiting December 2019 United States, California ... More >> Childrens Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027-0700 Contact: Araz Marachelian, MD    323-361-5687    amarachelian@chla.usc.edu    Lucile Salter Packer Children's Hospital Recruiting Palo Alto, California, United States, 94304 Contact: Sheri Spunt, MD          UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94115 Contact: Katherine Matthay, MD    415-476-3831    matthayK@peds.ucsf.edu    United States, Colorado Children Hospital of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Margaret Macy, MD    720-777-8856    Margaret.macy@childrenscolorado.org    United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelly Goldsmith, MD    404-785-0853    kgoldsm@emory.edu    United States, Illinois University of Chicago, Comer Children's Hospital Recruiting Chicago, Illinois, United States, 60637 Contact: Ami Desai, MD    773-843-3943    adesai12@peds.bsd.uchicago.edu    United States, Massachusetts Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02115 Contact: Suzanne Shusterman, MD    617-632-4901       United States, Michigan C.S Mott Children's Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Gregory Yanik, MD    734-936-8785    gyanik@umich.edu    United States, North Carolina University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Patrick Thompson, MD       patom@email.unc.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: Brian Weiss, MD    513-636-9863    brian.weiss@chmcc.org    United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104-4318 Contact: Yael Mosse, MD    215-590-0965    mosse@chop.edu    United States, Texas Cook Children's Healthcare System Recruiting Fort Worth, Texas, United States, 76104 Contact: Meaghan Granger, MD    682-885-4007       United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Navin Pinto, MD    206-987-5783    navin.pinto@seattlechildrens.org    Canada, Ontario Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G1X8 Contact: Meredith Irwin, MD Less <<
NCT00109109 Multiple Myeloma Phase 1 Terminated - -
NCT00423449 Non-Small Cell Lung Cancer Phase 1 Completed - -
NCT00423449 - Completed - -
NCT00574587 Breast Cancer Phase 1 Phase 2 Unknown January 2016 United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10461 Less <<
NCT00589472 Prostate Adenocarcinoma ... More >> Stage I Prostate Cancer Stage IIA Prostate Cancer Stage IIB Prostate Cancer Stage III Prostate Cancer Less << Phase 2 Completed - United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey UMDNJ - New Jersey Medical School Newark, New Jersey, United States, 07103 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington University of Washington Medical Center Seattle, Washington, United States, 98195 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT02943642 Mycosis Fungoides Phase 2 Not yet recruiting May 2020 -
NCT00589472 - Completed - -
NCT00473889 Stage IIIB or IV Non-Small Cel... More >>l Lung Cancer Less << Phase 2 Phase 3 Terminated(The study was termi... More >>nated based on the recommendation by the DSMB following a pre-planned protocol interim analysis because the endpoint was not achieved.) Less << - -
NCT01554852 Multiple Myeloma Phase 3 Active, not recruiting December 2022 United Kingdom ... More >> 112 sites UK wide United Kingdom, United Kingdom Less <<
NCT00455351 Pelvic Cancer|Radiotherapy PHASE1 COMPLETED 2025-08-09 The Norwegian Radium Hospital,... More >> Oslo, NO-0310, Norway Less <<
NCT00045006 Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00537121 Esophageal Cancer ... More >> Gastric Cancer Liver Cancer Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01076530 Childhood Atypical Teratoid/Rh... More >>abdoid Tumor Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Extra-adrenal Paraganglioma Recurrent Childhood Brain Stem Glioma Recurrent Childhood Central Nervous System Embryonal Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Spinal Cord Neoplasm Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma Less << Phase 1 Completed - United States, Illinois ... More >> Childrens Memorial Hospital Chicago, Illinois, United States, 60614 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, United States, 55455 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hospital Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT01386398 Lymphoma Phase 3 Withdrawn(Company withdrew int... More >>erest) Less << - -
NCT00324870 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 Peninsula Oncology and Hematology PA Salisbury, Maryland, United States, 21801 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00127127 Tumors Phase 1 Completed - -
NCT02083250 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia in Remission Allogeneic Hematopoietic Stem Cell Transplantation Recipient Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Acute Lymphoblastic Leukemia Recurrent Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting March 30, 2021 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00324870 - Completed - -
NCT01802333 Acute Myeloid Leukemia ... More >> Untreated Adult Acute Myeloid Leukemia Less << Phase 3 Completed - -
NCT03263936 Acute Myelogenous Leukemia Phase 1 Recruiting July 2020 -
NCT00555399 Glioblastoma Multiforme ... More >> Anaplastic Glioma Less << Phase 1 Phase 2 Active, not recruiting November 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01483690 Acute Lymphoblastic Leukemia ... More >> Precursor B-Cell Lymphoblastic Leukemia Precursor T-Cell Lymphoblastic Leukemia Less << Phase 1 Phase 2 Terminated(Toxicity) - -
NCT00473889 - Terminated(The study was termi... More >>nated based on the recommendation by the DSMB following a pre-planned protocol interim analysis because the endpoint was not achieved.) Less << - -
NCT00601718 - Completed - -
NCT00616967 Breast Cancer Phase 2 Completed - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35249 United States, Indiana Indiana University Purdue University of Indianapolis Indianapolis, Indiana, United States, 46202 United States, Maryland Anne Arundel Health System Annapolis, Maryland, United States, 21401 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00764517 - Completed - -
NCT00616967 - Completed - -
NCT00258349 Breast Cancer ... More >> Male Breast Cancer Recurrent Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Iowa Mercy Capitol Des Moines, Iowa, United States, 50307 Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Iowa Oncology Research Association CCOP Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates-Des Moines Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates Des Moines, Iowa, United States, 50314 Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 Siouxland Hematology Oncology Associates Sioux City, Iowa, United States, 51101 Mercy Medical Center-Sioux City Sioux City, Iowa, United States, 51104 Saint Luke's Regional Medical Center Sioux City, Iowa, United States, 51104 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Massachusetts Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 United States, Minnesota Hutchinson Area Health Care Hutchinson, Minnesota, United States, 55350 Meeker County Memorial Hospital Litchfield, Minnesota, United States, 55355 Saint John's Hospital - Healtheast Maplewood, Minnesota, United States, 55109 Virginia Piper Cancer Institute Minneapolis, Minnesota, United States, 55407 Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Regions Hospital Saint Paul, Minnesota, United States, 55101 Saint Joseph's Hospital - Healtheast Saint Paul, Minnesota, United States, 55102 Saint Francis Regional Medical Center Shakopee, Minnesota, United States, 55379 Woodwinds Health Campus Woodbury, Minnesota, United States, 55125 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 Montefiore Medical Center Bronx, New York, United States, 10467-2490 Saint Vincent's Hospital and Medical Center of New York New York, New York, United States, 10011 Less <<
NCT00764517 Recurrent B-Cell Non-Hodgkin L... More >>ymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Indolent Adult Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Less << Phase 2 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Less <<
NCT01801670 - Withdrawn(Enrollment was too s... More >>low, so no participants were ever enrolled.) Less << January 2015 United States, Massachusetts ... More >> Boston University Boston, Massachusetts, United States, 02118 Less <<
NCT00601718 Adult Nasal Type Extranodal NK... More >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Contiguous Stage II Mantle Cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Mantle Cell Lymphoma Stage I Mycosis Fungoides/Sezary Syndrome Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Mycosis Fungoides/Sezary Syndrome Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Mantle Cell Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Waldenstr?m Macroglobulinemia Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Puget Sound Oncology Consortium Seattle, Washington, United States, 98109 Less <<
NCT00258349 - Completed - -
NCT00867178 Medulloblastoma ... More >> Pineoblastoma Supratentorial Embryonal Tumor, Not Otherwise Specified Untreated Childhood Medulloblastoma Untreated Childhood Pineoblastoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Not Applicable Active, not recruiting - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Lurie Children's Hospital-Chicago Chicago, Illinois, United States, 60611 United States, Maryland National Cancer Institute Pediatric Oncology Branch Bethesda, Maryland, United States, 20892 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00357305 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Acute Promyelocytic Leukemia (M3) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Blastic Phase Chronic Myelogenous Leukemia Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia de Novo Myelodysplastic Syndromes Essential Thrombocythemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Maryland ... More >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01153672 - Completed - -
NCT01501370 Multiple Myeloma Phase 2 Withdrawn - Italy ... More >> Clinica di Ematologia, A.O.U. Ospedali Riuniti, Ospedale Umberto I di Ancona Ancona, Italy, 60020 U.O.S. di Ematologia, Ospedale Mazzoni Ascoli Piceno, Italy, 63100 Dh ematologia, A.O.U. Careggi Firenze, Italy, 50139 Ematologia, Ospedale S. Maria della Misericordia Perugia, Italy, 06156 Ematologia e Immunoematologia, Azienda Ospedaliera Riuniti Marche Nord Pesaro, Italy, 61100 Dip. Ematologia-U.O di Ematologia Generale-Azienda USL di Pescara-P.O. dello Spirito Santo Pescara, Italy, 65100 Ematologia , A.O.U. Pisana Pisa, Italy, 56126 Universitaria di Ematologia, A.O.U. San Giovanni Battista di Torino, Torino, Italy, 10126 Less <<
NCT01153672 Male Breast Cancer ... More >> Recurrent Breast Cancer Stage IV Breast Cancer Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00719875 Advanced Breast Cancer PHASE1 COMPLETED 2025-06-13 Yale University School of Medi... More >>cine, New Haven, Connecticut, 06219, United States Less <<
NCT00278395 Recurrent Renal Cell Carcinoma... More >>|Stage IV Renal Cell Cancer Less << PHASE2 COMPLETED 2025-02-10 Cancer Therapy and Research Ce... More >>nter at The UT Health Science Center at San Antonio, San Antonio, Texas, 78229, United States|Institute for Drug Development, San Antonio, Texas, 78245, United States Less <<
NCT02108002 Von Hippel-Lindau Disease PHASE1 COMPLETED 2018-09-12 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT04339751 Cushing's Disease PHASE2 RECRUITING 2025-12-01 National Institutes of Health ... More >>Clinical Center, Bethesda, Maryland, 20892, United States Less <<
NCT04308330 Ewing Sarcoma|Rhabdomyosarcoma... More >>|Wilms Tumor|Neuroblastoma|Hepatoblastoma|Germ Cell Tumor Less << PHASE1 RECRUITING 2024-12-31 New York Medical College, Valh... More >>alla, New York, 10595, United States Less <<
NCT00336141 Colorectal Cancer PHASE1 COMPLETED 2025-04-09 USC/Norris Comprehensive Cance... More >>r Center, Los Angeles, California, 90033, United States Less <<
NCT00416130 Breast Cancer PHASE1|PHASE2 UNKNOWN 2025-01-15 National University Hospital, ... More >>Singapore, 149547, Singapore|National Cancer Centre, Singapore, 169610, Singapore Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.78mL

0.76mL

0.38mL

18.92mL

3.78mL

1.89mL

37.83mL

7.57mL

3.78mL

References

 

Historical Records

Categories